017 | Targeting Lipogenesis Promotes the Synergistic Effect of the Selective HDAC Inhibitor ITF3756 With Bortezomib in Colon Cancer Cells: Marzia Franzò1, Giovanni Pratelli1, Federica Affranchi2, Antonietta Notaro2, Michela Giuliano2, Sonia Emanuele1 | 1Department of Biomedicine, Neuroscience and Advanced Diagnostics, Biochemistry Building, University of Palermo, Italy; 2Department of Biological, Chemical and Pharmaceutical Sciences and Technologies, University of Palermo, Italy. J Biol Res 2026, 99 (s1). https://doi.org/10.4081/jbr.2026.15269.